Bronchopulmonary dysplasia: how can we improve its outcomes?

Area of Science:

• Neonatology
• Pediatric Pulmonology
• Developmental Biology

Background:

• Bronchopulmonary dysplasia (BPD) is a prevalent chronic lung disease in preterm infants.
• Despite nearly 50 years of neonatal care advancements, BPD incidence has not declined and may be rising.
• Increased survival of extremely preterm infants impacts BPD pathogenesis due to varying lung development stages.

Purpose of the Study:

• To review the evolving definitions of Bronchopulmonary dysplasia (BPD).
• To discuss prenatal and postnatal risk factors contributing to BPD development.
• To outline phased management strategies and future research directions for BPD.

Main Methods:

• Literature review of Bronchopulmonary dysplasia (BPD) definitions.
• Analysis of risk factors across prenatal and postnatal periods.
• Synthesis of current and phased management approaches for BPD.

Main Results:

• The definition of Bronchopulmonary dysplasia (BPD) has shifted from "old" to "new" criteria.
• Multiple prenatal and postnatal factors contribute to BPD pathogenesis.
• Management strategies for BPD are being adapted based on disease phases.

Conclusions:

• Bronchopulmonary dysplasia (BPD) remains a significant challenge in preterm infant care.
• Understanding evolving definitions and multifactorial risks is crucial for BPD management.
• Further research is needed to refine BPD prevention and treatment strategies.